If you're a new reader, you can sign up for our newsletters here.
Top Stories on TheBodyPRO.com: July 18, 2017
The Future of 2-Drug Regimens for People With HIV

Reducing the number of drugs in a treatment regimen lowers long-term drug exposure and potential drug toxicity or drug interactions. What can we expect in the future for two-drug regimens?

Follow us!

For even more of the latest HIV updates and news stories, or to share comments and questions, follow us @BodyPROHIV.

This Week in HIV Research: New Discovery in How HIV Hijacks a Cell

This week, a study finds a new key step in how HIV binds to CD4 cells, which could lead to the development of new HIV drugs.

Read More →

Impact of HIV, Age and Comorbidity on Depression and Quality of Life

Having HIV independently raised chances of depression and worse health-related quality of life, according to a new study.

Read More →

Should You Answer Medical Questions From Clinicians You Don't Know About Patients You've Never Seen?

"There are a few reasons not to answer questions from clinicians you've never met about patients you haven't seen," writes Paul Sax, M.D.

Read More →

Long-Acting Injectables for PrEP: Will the Tail Wag the Drug?

Investigational Hepatitis C Drugs Show Promising Results

Increased Risk of Death Among HIV-Positive Indigenous People in Canada

In Case You Missed It: